Lyra Therapeutics Stock Price History
LYRA Stock | USD 0.16 0.01 5.88% |
If you're considering investing in Lyra Stock, it is important to understand the factors that can impact its price. As of today, the current price of Lyra Therapeutics stands at 0.16, as last reported on the 20th of March, with the highest price reaching 0.16 and the lowest price hitting 0.14 during the day. Lyra Therapeutics has Sharpe Ratio of -0.0264, which conveys that the firm had a -0.0264 % return per unit of risk over the last 3 months. Lyra Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lyra Therapeutics' Risk Adjusted Performance of (0.02), mean deviation of 2.61, and Standard Deviation of 4.19 to check out the risk estimate we provide.
Lyra Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Lyra |
Sharpe Ratio = -0.0264
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | LYRA |
Estimated Market Risk
4.19 actual daily | 37 63% of assets are more volatile |
Expected Return
-0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lyra Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lyra Therapeutics by adding Lyra Therapeutics to a well-diversified portfolio.
Lyra Therapeutics Stock Price History Chart
There are several ways to analyze Lyra Stock price data. The simplest method is using a basic Lyra candlestick price chart, which shows Lyra Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | December 30, 2024 | 0.22 |
Lowest Price | March 18, 2025 | 0.16 |
Lyra Therapeutics March 20, 2025 Stock Price Synopsis
Various analyses of Lyra Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Lyra Stock. It can be used to describe the percentage change in the price of Lyra Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Lyra Stock.Lyra Therapeutics Price Daily Balance Of Power | (0.50) | |
Lyra Therapeutics Price Rate Of Daily Change | 0.94 |
Lyra Therapeutics March 20, 2025 Stock Price Analysis
Lyra Stock Price History Data
The price series of Lyra Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 0.06 with a coefficient of variation of 7.92. The daily prices for the period are spread out with arithmetic mean of 0.19. The median price for the last 90 days is 0.19.Open | High | Low | Close | Volume | ||
03/20/2025 | 0.15 | 0.16 | 0.14 | 0.16 | ||
03/19/2025 | 0.15 | 0.16 | 0.14 | 0.16 | 877,846 | |
03/18/2025 | 0.17 | 0.17 | 0.16 | 0.16 | 951,300 | |
03/17/2025 | 0.18 | 0.18 | 0.16 | 0.17 | 1,481,919 | |
03/14/2025 | 0.17 | 0.18 | 0.17 | 0.17 | 1,375,982 | |
03/13/2025 | 0.18 | 0.19 | 0.18 | 0.18 | 936,823 | |
03/12/2025 | 0.18 | 0.19 | 0.18 | 0.18 | 481,196 | |
03/11/2025 | 0.18 | 0.19 | 0.18 | 0.18 | 591,479 | |
03/10/2025 | 0.19 | 0.19 | 0.18 | 0.18 | 1,277,476 | |
03/07/2025 | 0.19 | 0.20 | 0.19 | 0.19 | 1,955,854 | |
03/06/2025 | 0.19 | 0.19 | 0.18 | 0.19 | 628,918 | |
03/05/2025 | 0.18 | 0.19 | 0.18 | 0.19 | 391,362 | |
03/04/2025 | 0.19 | 0.19 | 0.18 | 0.18 | 948,099 | |
03/03/2025 | 0.21 | 0.21 | 0.19 | 0.19 | 726,036 | |
02/28/2025 | 0.20 | 0.22 | 0.19 | 0.21 | 1,189,974 | |
02/27/2025 | 0.20 | 0.21 | 0.20 | 0.20 | 560,057 | |
02/26/2025 | 0.20 | 0.22 | 0.20 | 0.21 | 580,151 | |
02/25/2025 | 0.20 | 0.21 | 0.20 | 0.20 | 730,743 | |
02/24/2025 | 0.21 | 0.22 | 0.20 | 0.21 | 1,498,309 | |
02/21/2025 | 0.20 | 0.22 | 0.20 | 0.21 | 1,103,228 | |
02/20/2025 | 0.20 | 0.20 | 0.19 | 0.20 | 907,549 | |
02/19/2025 | 0.20 | 0.21 | 0.19 | 0.20 | 603,236 | |
02/18/2025 | 0.21 | 0.21 | 0.20 | 0.21 | 899,769 | |
02/14/2025 | 0.21 | 0.22 | 0.20 | 0.21 | 1,516,420 | |
02/13/2025 | 0.20 | 0.22 | 0.19 | 0.21 | 1,397,144 | |
02/12/2025 | 0.19 | 0.20 | 0.19 | 0.20 | 683,385 | |
02/11/2025 | 0.19 | 0.21 | 0.19 | 0.20 | 1,613,720 | |
02/10/2025 | 0.19 | 0.20 | 0.18 | 0.19 | 2,511,941 | |
02/07/2025 | 0.19 | 0.20 | 0.19 | 0.19 | 1,072,342 | |
02/06/2025 | 0.19 | 0.20 | 0.18 | 0.19 | 510,535 | |
02/05/2025 | 0.18 | 0.19 | 0.18 | 0.19 | 474,878 | |
02/04/2025 | 0.18 | 0.19 | 0.18 | 0.18 | 758,334 | |
02/03/2025 | 0.18 | 0.19 | 0.18 | 0.18 | 415,250 | |
01/31/2025 | 0.18 | 0.19 | 0.18 | 0.18 | 530,122 | |
01/30/2025 | 0.19 | 0.19 | 0.18 | 0.18 | 571,822 | |
01/29/2025 | 0.18 | 0.19 | 0.18 | 0.18 | 735,506 | |
01/28/2025 | 0.19 | 0.19 | 0.18 | 0.18 | 745,785 | |
01/27/2025 | 0.19 | 0.20 | 0.18 | 0.19 | 657,047 | |
01/24/2025 | 0.19 | 0.19 | 0.18 | 0.19 | 427,106 | |
01/23/2025 | 0.19 | 0.20 | 0.19 | 0.19 | 863,845 | |
01/22/2025 | 0.19 | 0.20 | 0.19 | 0.19 | 505,128 | |
01/21/2025 | 0.20 | 0.20 | 0.19 | 0.19 | 885,399 | |
01/17/2025 | 0.19 | 0.19 | 0.19 | 0.19 | 454,817 | |
01/16/2025 | 0.19 | 0.19 | 0.18 | 0.19 | 742,240 | |
01/15/2025 | 0.19 | 0.19 | 0.18 | 0.19 | 1,843,279 | |
01/14/2025 | 0.19 | 0.20 | 0.19 | 0.19 | 1,287,935 | |
01/13/2025 | 0.20 | 0.20 | 0.19 | 0.20 | 1,371,058 | |
01/10/2025 | 0.19 | 0.21 | 0.19 | 0.20 | 1,685,999 | |
01/08/2025 | 0.21 | 0.21 | 0.20 | 0.20 | 1,280,933 | |
01/07/2025 | 0.21 | 0.22 | 0.21 | 0.22 | 1,197,289 | |
01/06/2025 | 0.21 | 0.22 | 0.20 | 0.22 | 2,519,616 | |
01/03/2025 | 0.21 | 0.21 | 0.18 | 0.21 | 3,356,926 | |
01/02/2025 | 0.21 | 0.23 | 0.20 | 0.22 | 1,878,542 | |
12/31/2024 | 0.24 | 0.24 | 0.20 | 0.21 | 3,326,600 | |
12/30/2024 | 0.19 | 0.25 | 0.19 | 0.22 | 5,510,621 | |
12/27/2024 | 0.18 | 0.21 | 0.18 | 0.19 | 1,821,451 | |
12/26/2024 | 0.18 | 0.19 | 0.17 | 0.18 | 1,427,762 | |
12/24/2024 | 0.17 | 0.18 | 0.17 | 0.17 | 610,736 | |
12/23/2024 | 0.19 | 0.19 | 0.16 | 0.17 | 1,211,348 | |
12/20/2024 | 0.17 | 0.19 | 0.17 | 0.18 | 2,250,103 | |
12/19/2024 | 0.17 | 0.18 | 0.17 | 0.17 | 1,689,000 |
About Lyra Therapeutics Stock history
Lyra Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lyra is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lyra Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lyra Therapeutics stock prices may prove useful in developing a viable investing in Lyra Therapeutics
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts. Lyra Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 60 people.
Lyra Therapeutics Stock Technical Analysis
Lyra Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Lyra Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lyra Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Lyra Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lyra to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.13) | |||
Total Risk Alpha | 0.2329 | |||
Treynor Ratio | 1.06 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Lyra Stock analysis
When running Lyra Therapeutics' price analysis, check to measure Lyra Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lyra Therapeutics is operating at the current time. Most of Lyra Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lyra Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lyra Therapeutics' price. Additionally, you may evaluate how the addition of Lyra Therapeutics to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |